FDA grants BDD for Roche’s Elecsys GDF-15 assay addressing cancer weight loss
Roche has revealed that their assay Elecsys® GDF-15 assay has been approved as a companion diagnostic (CDx) in cancer therapy
Read moreRoche has revealed that their assay Elecsys® GDF-15 assay has been approved as a companion diagnostic (CDx) in cancer therapy
Read moreThe next-gen TissueFAXS Q confocal imaging systems are highly flexible scanning platforms which offer the advantages of both laser-free ultra-fast
Read moreThe StrataQuest AI-assisted high-content screening (HCS) image cytometry software offers solutions for multiple applications in analysing large volumes of complex
Read moreThe cutting-edge TissueFAXS PLUS high-content screening system by TissueGnostics is engineered for advanced multi-channel fluorescence microscopy and exceptional high-resolution imaging
Read moreThe NYONE® is a new-gen compact medium-throughput cell imager, designed as an ideal solution to save on costs and laboratory
Read morePfizer and BioNTech have published early in vitro study data showing that the BNT162b2 COVID-19 vaccine generates antibodies that neutralise
Read moreThe CELLAVISTA® 4 is a cutting-edge automated ultrahigh-throughput imaging system able to scan a 96 well microplate at 10X magnification
Read moreHarbour BioMed, a global clinical stage biopharmaceutical company developing novel therapeutics in the fields of immuno-oncology, immunologic diseases, and COVID-19,
Read moreAbbVie, Harbour BioMed, Utrecht University and the Erasmus Medical Center (EMC) revealed today they have entered into a partnership to
Read moreScientists at clinical-stage biopharmaceutical company Harbour BioMed (HBM), Utrecht University and Erasmus Medical Center announced that they have discovered a
Read more